These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 20445837

  • 1. Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD.
    Reimherr FW, Marchant BK, Williams ED, Strong RE, Halls C, Soni P.
    Ann Clin Psychiatry; 2010 May; 22(2):103-12. PubMed ID: 20445837
    [Abstract] [Full Text] [Related]

  • 2. Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate.
    Williams ED, Reimherr FW, Marchant BK, Strong RE, Halls C, Soni P, Gale PD, Robison RJ.
    Ann Clin Psychiatry; 2010 May; 22(2):84-93. PubMed ID: 20445835
    [Abstract] [Full Text] [Related]

  • 3. Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.
    Robison RJ, Reimherr FW, Gale PD, Marchant BK, Williams ED, Soni P, Halls C, Strong RE.
    Ann Clin Psychiatry; 2010 May; 22(2):94-102. PubMed ID: 20445836
    [Abstract] [Full Text] [Related]

  • 4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 5. OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
    Marchant BK, Reimherr FW, Halls C, Williams ED, Strong RE.
    Ann Clin Psychiatry; 2010 Aug; 22(3):196-204. PubMed ID: 20680193
    [Abstract] [Full Text] [Related]

  • 6. Oppositional defiant disorder in adults with ADHD.
    Reimherr FW, Marchant BK, Olsen JL, Wender PH, Robison RJ.
    J Atten Disord; 2013 Feb; 17(2):102-13. PubMed ID: 22100691
    [Abstract] [Full Text] [Related]

  • 7. Relationships of neuroticism and extraversion with axis I and II comorbidity among patients with DSM-IV major depressive disorder.
    Jylhä P, Melartin T, Isometsä E.
    J Affect Disord; 2009 Apr; 114(1-3):110-21. PubMed ID: 18687471
    [Abstract] [Full Text] [Related]

  • 8. Inattention and hyperactivity dimensions of ADHD are associated with different personality profiles.
    Salgado CA, Bau CH, Grevet EH, Fischer AG, Victor MM, Kalil KL, Sousa NO, Garcia CR, Belmonte-de-Abreu P.
    Psychopathology; 2009 Apr; 42(2):108-12. PubMed ID: 19225245
    [Abstract] [Full Text] [Related]

  • 9. Severity of childhood attention-deficit hyperactivity disorder--a risk factor for personality disorders in adult life?
    Matthies S, van Elst LT, Feige B, Fischer D, Scheel C, Krogmann E, Perlov E, Ebert D, Philipsen A.
    J Pers Disord; 2011 Feb; 25(1):101-14. PubMed ID: 21309626
    [Abstract] [Full Text] [Related]

  • 10. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
    Levin FR, Evans SM, Brooks DJ, Garawi F.
    Drug Alcohol Depend; 2007 Feb 23; 87(1):20-9. PubMed ID: 16930863
    [Abstract] [Full Text] [Related]

  • 11. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P, Sever J, Zalsman G, Weizman A.
    Int Clin Psychopharmacol; 2008 Jul 23; 23(4):228-31. PubMed ID: 18446088
    [Abstract] [Full Text] [Related]

  • 12. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr 23; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 13. Frequency of comorbid personality disorders in bipolar and unipolar affective disorders.
    Brieger P, Ehrt U, Marneros A.
    Compr Psychiatry; 2003 Apr 23; 44(1):28-34. PubMed ID: 12524633
    [Abstract] [Full Text] [Related]

  • 14. Personality Disorder in Adult Attention-Deficit/Hyperactivity Disorder: Attrition and Change During Long-term Treatment.
    Gift TE, Reimherr FW, Marchant BK, Steans TA, Wender PH.
    J Nerv Ment Dis; 2016 May 23; 204(5):355-63. PubMed ID: 27082828
    [Abstract] [Full Text] [Related]

  • 15. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E, Banaschewski T, Asherson P, Buitelaar J, Chen W, Franke B, Holtmann M, Krumm B, Sergeant J, Sonuga-Barke E, Stringaris A, Taylor E, Anney R, Ebstein RP, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Steinhausen HC, Faraone SV.
    J Child Psychol Psychiatry; 2010 Aug 23; 51(8):915-23. PubMed ID: 20132417
    [Abstract] [Full Text] [Related]

  • 16. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS, Ni HC, Shang CY, Soong WT, Wu YY, Lin LY, Chiu YN.
    Aust N Z J Psychiatry; 2010 Feb 23; 44(2):135-43. PubMed ID: 20113302
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 2010 Feb 23; 16(2):1-37. PubMed ID: 10868163
    [Abstract] [Full Text] [Related]

  • 18. Axis I and II comorbidity in adults with ADHD.
    Miller TW, Nigg JT, Faraone SV.
    J Abnorm Psychol; 2007 Aug 23; 116(3):519-28. PubMed ID: 17696708
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R.
    Clin Ther; 2006 Mar 23; 28(3):402-18. PubMed ID: 16750455
    [Abstract] [Full Text] [Related]

  • 20. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group.
    Eur Neuropsychopharmacol; 2009 Nov 23; 19(11):822-34. PubMed ID: 19716683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.